Perioperatieve chemo-immunotherapie is op de lange termijn veelbelovend als behandeling van resectabel stadium IIIA NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback